The Government of Ontario has announced it is consulting with patients, healthcare providers, and the pharmaceutical and medical devices industries about current regulations and guidelines that govern the disclosure of payments from the private sector to healthcare professionals. Although some innovative pharmaceutical companies already voluntarily disclose payments to healthcare providers, Ontario is assessing what additional measures should be implemented to increase transparency, including possibly mandating disclosure of payments by private drug companies to healthcare providers.
Link:
Ontario Consulting on Transparency in the Health Care Sector
